ConductScience.org, home

Paper29312973

Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma.

Xie DY and 4 others. Hepatobiliary Surg Nutr, 2017. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma. Papers, record 29312973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29312973

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma.
PubMed
Journal
Hepatobiliary Surg Nutr
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
2.21
iCite
Revised in PubMed
2022-03-31
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xie DYDi-Yang
2Ren ZGZheng-Gang
3Zhou JJian
4Fan JJia
5Gao QQiang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in29532810Hepatocellular carcinoma: one world, one cancer-different guidelines?https://conductscience.org/library/papers/29532810PubMed
Comment in30221159Searching for common ground in a global disease.https://conductscience.org/library/papers/30221159PubMed

Download CSV of comments and corrections

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125027973A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.J Gastroenterol2015https://conductscience.org/library/papers/25027973PubMed
227781197Surgery for Intermediate and Advanced Hepatocellular Carcinoma: A Consensus Report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).Liver Cancer2016https://conductscience.org/library/papers/27781197PubMed
3287524698th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers.Ann Surg Oncol2018https://conductscience.org/library/papers/28752469PubMed
421374666Management of hepatocellular carcinoma: an update.Hepatology2011https://conductscience.org/library/papers/21374666PubMed
526280007JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.Liver Cancer2014https://conductscience.org/library/papers/26280007PubMed
620512990Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.Hepatology2010https://conductscience.org/library/papers/20512990PubMed
720175034Current strategy for staging and treatment: the BCLC update and future prospects.Semin Liver Dis2010https://conductscience.org/library/papers/20175034PubMed
825612807Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.J Vasc Interv Radiol2015https://conductscience.org/library/papers/25612807PubMed
917522506A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma.Ann Surg2007https://conductscience.org/library/papers/17522506PubMed
1019916210The international position on laparoscopic liver surgery: The Louisville Statement, 2008.Ann Surg2009https://conductscience.org/library/papers/19916210PubMed
1128620797Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.Hepatol Int2017https://conductscience.org/library/papers/28620797PubMed
1226079914Safety of ALPPS Procedure by the Anterior Approach for Hepatocellular Carcinoma.Ann Surg2016https://conductscience.org/library/papers/26079914PubMed
1321829027Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.Dig Dis2011https://conductscience.org/library/papers/21829027PubMed
1425981135Downstaging hepatocellular carcinoma: A systematic review and pooled analysis.Liver Transpl2015https://conductscience.org/library/papers/25981135PubMed
1511391528Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.Hepatology2001https://conductscience.org/library/papers/11391528PubMed
1624886354Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis.BMC Gastroenterol2014https://conductscience.org/library/papers/24886354PubMed
1725773941Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout?Eur Radiol2015https://conductscience.org/library/papers/25773941PubMed
1826765068Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.Hepatology2016https://conductscience.org/library/papers/26765068PubMed
1925379854Early survival and safety of ALPPS: first report of the International ALPPS Registry.Ann Surg2014https://conductscience.org/library/papers/25379854PubMed
2028485409Immunotherapy: Nivolumab keeps HCC in check and opens avenues for checkmate.Nat Rev Clin Oncol2017https://conductscience.org/library/papers/28485409PubMed

See all 66 referencesDownload CSV of references

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
42170426Significance of surgical margin width versus anatomical resection for hepatocellular carcinoma.Am J Transl Res2026https://conductscience.org/library/papers/42170426PubMed
40547955Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular Carcinoma.Liver Cancer2025https://conductscience.org/library/papers/40547955PubMed
40060905Serum-biomarker-based population screening model for hepatocellular carcinoma.iScience2025https://conductscience.org/library/papers/40060905PubMed
39759152Clinicopathologic and ultrasonographic features of combined hepatocellular-cholangiocarcinoma and its correlation with microvascular invasion: a predictive role of contrast-enhanced ultrasound.Front Oncol2024https://conductscience.org/library/papers/39759152PubMed
39399114Development of prognostic models for advanced multiple hepatocellular carcinoma based on Cox regression, deep learning and machine learning algorithms.Front Med (Lausanne)2024https://conductscience.org/library/papers/39399114PubMed
38797901Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review.Curr Pharm Des2024https://conductscience.org/library/papers/38797901PubMed
38438972Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.BMC Gastroenterol2024https://conductscience.org/library/papers/38438972PubMed
37041364Surgical resection for large hepatocellular carcinoma and those beyond BCLC: systematic review with proposed management algorithm.Langenbecks Arch Surg2023https://conductscience.org/library/papers/37041364PubMed
36619232LncRNA RPPH1 acts as a molecular sponge for miR-122 to regulate Wnt1/β-catenin signaling in hepatocellular carcinoma.Int J Med Sci2023https://conductscience.org/library/papers/36619232PubMed
36246809Effects of targeted-edited oncogenic insulin-like growth factor-1 receptor with specific-sgRNA on biological behaviors of HepG2 cells.World J Clin Cases2022https://conductscience.org/library/papers/36246809PubMed
34824186Role of Tumor Biomarkers in the Surveillance of Hepatocellular Carcinoma.Korean J Gastroenterol2021https://conductscience.org/library/papers/34824186PubMed
34777698miR-4454 Promotes Hepatic Carcinoma Progression by Targeting Vps4A and Rab27A.Oxid Med Cell Longev2021https://conductscience.org/library/papers/34777698PubMed
34773467Can modified LI-RADS increase the sensitivity of LI-RADS v2018 for the diagnosis of 10-19 mm hepatocellular carcinoma on gadoxetic acid-enhanced MRI?Abdom Radiol (NY)2022https://conductscience.org/library/papers/34773467PubMed
34715816Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.BMC Cancer2021https://conductscience.org/library/papers/34715816PubMed
33860031Development and Evaluation of Nomograms to Predict the Cancer-Specific Mortality and Overall Mortality of Patients with Hepatocellular Carcinoma.Biomed Res Int2021https://conductscience.org/library/papers/33860031PubMed
33330822Difference in treatment algorithms for hepatocellular carcinoma between world's principal guidelines.Glob Health Med2020https://conductscience.org/library/papers/33330822PubMed
33297335Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives.Biomedicines2020https://conductscience.org/library/papers/33297335PubMed
33097694Epigenetic silencing of ZIC4 contributes to cancer progression in hepatocellular carcinoma.Cell Death Dis2020https://conductscience.org/library/papers/33097694PubMed
32884985Advances in the early diagnosis of hepatocellular carcinoma.Genes Dis2020https://conductscience.org/library/papers/32884985PubMed
32646378The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia.BMC Gastroenterol2020https://conductscience.org/library/papers/32646378PubMed

See all 39 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AFP174PubTator's text mininghttps://conductscience.org/library/genes/174

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29312973

GET https://conductscience.org/api/papers/v1/29312973/references?page=2